XML 40 R30.htm IDEA: XBRL DOCUMENT v3.22.2.2
Collaboration agreements - GlaxoSmithKline (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Aug. 31, 2022
Collaboration agreements          
Collaboration revenue $ 5,573,000 $ 11,000 $ 11,893,000 $ 32,000  
GSK Agreement          
Collaboration agreements          
Deferred revenue 99,300,000   99,300,000   $ 100,000,000
Collaboration arrangement, potential option exercise receivable         90,000,000
Collaboration revenue 700,000        
Contract assets $ 0   $ 0    
GSK Agreement | Development, Regulatory & Commercial          
Collaboration agreements          
Collaboration arrangements, maximum aggregate milestones         1,300,000,000
GSK Agreement | Early Clinical Development          
Collaboration agreements          
Collaboration arrangements, maximum aggregate milestones         $ 30,000,000